pharma-company /Medicinal products /Active ingredients

Rx · PZN 16596911, 16596928

RUKOBIA 600 mg prolonged-release tablets

German trade nameRUKOBIA 600 mg Retardtabletten

Active ingredientFostemsavirPharmaceutical formProlonged-release tablets

Available with fluctuations

5.3

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €4,251

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for RUKOBIA 600 mg prolonged-release tablets.

Review purchasing terms

RUKOBIA 600 mg prolonged-release tablets contains the active ingredient Fostemsavir and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 5.3 out of 10. The best-available pack was available with fluctuations.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
165969115.35.3~ €2,126
165969280.00.0~ €6,376

Availability of RUKOBIA 600 mg prolonged-release tablets fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.